enoxacin has been researched along with Obesity in 1 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we tested whether widespread changes in miRNA expression promoted by treatment with the small-molecule enoxacin cause browning and prevent obesity." | 7.96 | Enoxacin induces oxidative metabolism and mitigates obesity by regulating adipose tissue miRNA expression. ( Auwerx, J; Boucher, J; Carvalho, HF; Castro, PR; Corrêa, RO; de Lima, TI; de Souza, GP; Dos Santos Martins, F; Fernandes, MF; Ferrucci, DL; Knittel, TL; Lopes-Ramos, C; Mori, MA; Nilsson, D; Parmigiani, RB; Rocha, AL; Rodrigues, B; Silveira, LR; Vinolo, MAR, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rocha, AL | 1 |
| de Lima, TI | 1 |
| de Souza, GP | 1 |
| Corrêa, RO | 1 |
| Ferrucci, DL | 1 |
| Rodrigues, B | 1 |
| Lopes-Ramos, C | 1 |
| Nilsson, D | 1 |
| Knittel, TL | 1 |
| Castro, PR | 1 |
| Fernandes, MF | 1 |
| Dos Santos Martins, F | 1 |
| Parmigiani, RB | 1 |
| Silveira, LR | 1 |
| Carvalho, HF | 1 |
| Auwerx, J | 1 |
| Vinolo, MAR | 1 |
| Boucher, J | 1 |
| Mori, MA | 1 |
1 other study available for enoxacin and Obesity
| Article | Year |
|---|---|
Enoxacin induces oxidative metabolism and mitigates obesity by regulating adipose tissue miRNA expression.
Topics: Adipose Tissue, Brown; Animals; Energy Metabolism; Enoxacin; Mice; Mice, Inbred C57BL; MicroRNAs; Ob | 2020 |